Fairfield Financial Advisors, LTD Organon & Co. Transaction History

Fairfield Financial Advisors, LTD

  • $284 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Oct 07, 2024
SELL
$23.31 - $28.61 $303 - $371
-13 Closed
0 $0
Q3 2022

Oct 07, 2024
BUY
$23.4 - $34.25 $304 - $445
13 New
13 $293,000
Q2 2022

Oct 07, 2024
BUY
$31.66 - $38.9 $379 - $466
12 New
12 $419,000
Q1 2022

Oct 07, 2024
BUY
$30.45 - $39.36 $548 - $708
18 New
18 $640,000

Others Institutions Holding OGN

# of Institutions
799
Shares Held
205M
Call Options Held
1.45M
Put Options Held
870K
View Full List

About Organon & Co.

OGN Quotes by TradingView
  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.74B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Fairfield Financial Advisors, LTD Portfolio

Follow Fairfield Financial Advisors, LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fairfield Financial Advisors, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fairfield Financial Advisors, LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email